Skip to content

National Jewish Health and Siemens Healthineers Announce Strategic Partnership


National Jewish Health, the leading respiratory hospital in the nation, and Siemens Healthineers, a global medical technology leader, have extended their existing strategic relationship to form a Value Partnership. The agreement will set the foundation for future initiatives together to advance the care of patients with respiratory, cardiovascular, immune and related diseases.

National Jewish Health and Siemens Healthineers have worked together over the past two decades on strategic initiatives developing novel imaging and diagnostic technologies that have advanced precision medicine. Past collaborations have resulted in improvements in the diagnosis of respiratory, cardiology and rheumatologic diseases.

 “National Jewish Health has long worked with Siemens for technology to help ensure that our patients, faculty and researchers have access to the best and latest imaging and diagnostic technologies available. We are excited to now be announcing this expanded agreement with Siemens Healthineers,” said Michael Salem, MD, president and CEO of National Jewish Health. “We are at the forefront of respiratory, cardiac and immune disease research and care for children and adults, and we look forward to working together on new joint research projects that advance medicine.”

The agreement is part of a comprehensive strategy that establishes a close relationship between the two organizations facilitating collaboration, integration and innovation, that in turn, will advance leading-edge health care initiatives. The Value Partnership aligns with the National Jewish Health core technology strategy and aims to develop technology management plans that leverage the strengths and technology expertise of Siemens Healthineers particularly for imaging, diagnostic testing, analytics, clinical workflows and staffing support programs.

“Long-term relationships such as this Value Partnership are key to fostering innovation to improve patient care,” said David Pacitti, president and head of the Americas at Siemens Healthineers. “We greatly appreciate the trust and confidence National Jewish Health has shown in us as a partner and are excited about what we can accomplish together.”

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at

National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.

We have many faculty members, from bench scientists to clinicians, who can speak on almost any aspect of respiratory, immune, cardiac and gastrointestinal disease as well as lung cancer and basic immunology.

Our team is available to arrange interviews, discuss events and story ideas.